PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

U.S. Cancer In-Vitro Diagnostics Markets - New analysis from Frost and Sullivan, U.S. Cancer In-Vitro Diagnostics Markets, reveals that the market accrued revenues of $881.5 million in 2005 and estimates it to reach $2.3 billion by 2012
U.S. Cancer In-Vitro Diagnostics Markets

 

NewswireToday - /newswire/ - Palo Alto, CA, United States, 2006/11/21 - New analysis from Frost and Sullivan, U.S. Cancer In-Vitro Diagnostics Markets, reveals that the market accrued revenues of $881.5 million in 2005 and estimates it to reach $2.3 billion by 2012.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The number of Americans suffering from cancer is escalating at a substantial rate. This is significantly increasing the demand for diagnostic tests. As the new guidelines for cancer management in the United States mandate more quantitative and non-invasive testing as part of therapeutic management, all types of cancer in-vitro diagnostic (IVD) tests are witnessing growing demand.

New analysis from Frost and Sullivan, U.S. Cancer In-Vitro Diagnostics Markets, reveals that the market accrued revenues of $881.5 million in 2005 and estimates it to reach $2.3 billion by 2012.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Cancer In-Vitro Diagnostics Markets, then send an e-mail to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

Introduction of several new testing technologies is creating opportunities in the areas of cancer risk assessment, screening, prognosis, and treatment monitoring.

Centers for Medicare and Medicaid Services (CMS) and private payer reimbursement schemes include many types of nucleic acid test (NAT) diagnostic tests. This increases payer adoption, which in turn drives physician adoption of NATs, impelling the cancer IVD market.

Market participants are increasing installed base and establishing long-term reagent contracts for their instruments. This value proposition also includes servicing instruments installed in laboratories.

“These reagent revenues can account for long-term and stable sources of income for market participants,” observes Frost & Sullivan Research Analyst Martin Nejat.

However, the U.S. clinical laboratory is facing several types of pressure. These include labor and staff shortage, cost pressures, keeping pace with technical advances, and producing timely results.

Automated and integrated platforms can provide some relief to the clinical laboratory by increasing throughput while requiring less dedicated technician time. Integrated platforms can also reduce workload, improve data analysis and storage, and reduce the complexity that is inherent in working with different types of instruments.

“Market participants can take advantage of this opportunity to garner larger revenues by developing and introducing automated platforms for the immunoassay and advanced staining segments of the cancer IVD market,” cites Nejat.

There is active involvement of market participants in the development and validation of new molecular, immunoassay, and advanced staining tests. However, validation of new assays along with development costs associated with biomarker validation and attainment of patient samples can significantly challenge market participants.

Clinical utility of the assay, reimbursement, breadth of instrument menu, cost, quality, and reliability of assay are other areas market participants need to focus on. The assay must prove to be affordable and provide value to the patient and physician. It is also essential that the company demonstrate the product’s economic benefit to insurance payers.

Market participants are formulating relationships or collaborations with institutions along the entire IVD market value chain. Collaboration with clinical reference laboratories is crucial to penetrate the market.

Partnerships with academic and research institutions are principal for biomarker development and validation of new assays. Small companies that offer innovative technologies, assays, or other diagnostic products can benefit by these partnerships to acquire larger revenues.

The U.S. Cancer In-Vitro Diagnostics Markets is part of the Clinical Diagnostics subscription, which also includes research in the following markets: immunoassay diagnostics, molecular diagnostics, point-of-care diagnostics, and infectious diseases diagnostics. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Analyst interviews are available to the press.

Frost and Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost and Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


U.S. Cancer In-Vitro Diagnostics Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Melina Trevino 
210.247.2447 melina.trevino[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)